Pooled analysis of a self-sampling HPV DNA test as a cervical cancer primary screening method

Journal of the National Cancer Institute

Volumn 104, Issue 3, 2012, Pages 178-188

  Zhao, Fang Hui ^a   Lewkowitz, Adam K ^b   Chen, Feng ^a   Lin, Margaret J ^c   Hu, Shang Ying ^a   Zhang, Xun ^a   Pan, Qin Jing ^a   Ma, Jun Fei ^d   Niyazi, Mayineur ^e   Li, Chang Qing ^f   Li, Shu Min ^a   Smith, Jennifer S ^g   Belinson, Jerome L ^h,i   Qiao, You Lin ^a   Castle, Philip E ^j  

^a CANCER HOSPITAL   (China)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d Xiangyuan County Women and Children Hospital   (China)

^e Xinjiang Uygur Autonomous Region People's Hospital   (China)

^f Xinmi City Women and Children Hospital   (China)

^g The University of North Carolina at Chapel Hill   (United States)

^h Preventive Oncology International Inc   (United States)

ⁱ LERNER RESEARCH INSTITUTE   (United States)

^j American Society for Clinical Pathology Institute   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ARTICLE; CANCER CYTODIAGNOSIS; CANCER DIAGNOSIS; CANCER SCREENING; CHINA; COLPOSCOPY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; FEMALE; FLUORESCENCE ANALYSIS; GOLD STANDARD; GYNECOLOGICAL EXAMINATION; HUMAN; INTERMETHOD COMPARISON; LIQUID BASED CYTOLOGY; LOWEST INCOME GROUP; MEDICAL EXAMINATION; META ANALYSIS; PHYSICIAN; PRIORITY JOURNAL; SCREENING TEST; SELF EXAMINATION; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VISUAL INSPECTION; WART VIRUS; WART VIRUS DNA TEST;

ALPHAPAPILLOMAVIRUS; BIOPSY; CERVICAL INTRAEPITHELIAL NEOPLASIA; CHINA; COLPOSCOPY; DNA, VIRAL; EARLY DETECTION OF CANCER; FEMALE; HUMANS; NEOPLASM GRADING; PAPILLOMAVIRUS INFECTIONS; ROC CURVE; RURAL POPULATION; SELF-EXAMINATION; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 84863116298     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djr532     Document Type: Article

References (42)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893-2917.
2. International Agency for Research on Cancer (IARC). IARC Handbooks of Cancer Prevention: Cervix Cancer Screening, Chapter 2. Lyon, France: IARC Press; 2005.
3. Belinson J, Qiao YL, Pretorius R, et al. Shanxi Province Cervical Cancer Screening Study: a cross-sectional comparative trial of multiple techniques to detect cervical neoplasia. Gynecol Oncol. 2001;83(2):439-444. (Pubitemid 33033096)
4. The Lancet. Women's health in rural China. Lancet. 2009;374(9687):358.
5. Cuzick J, Clavel C, Petry KU, et al. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer. 2006;119(5):1095-1101. (Pubitemid 44116919)
6. Arbyn M, Ronco G, Meijer CJ, Naucler P. Trials comparing cytology with human papillomavirus screening. Lancet Oncol. 2009;10(10):935-936.
7. Schiffman M, Wentzensen N, Wacholder S, Kinney W, Gage JC, Castle PE. Human papillomavirus testing in the prevention of cervical cancer. J Natl Cancer Inst. 2011;103(5):368-383.
8. Franco EL. A new generation of studies in human papillomavirus DNA testing in cervical cancer screening. J Natl Cancer Inst. 2009;101(23):1600- 1601.
9. Ronco G, Giorgi-Rossi P, Carozzi F, et al. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. Lancet Oncol. 2010;11(3):249-257.
10. Zhao FH, Lin MJ, Chen F, et al. Performance of high-risk human papillomavirus DNA testing as a primary screen for cervical cancer: a pooled analysis of individial patient data from 17 population-based studies from China. Lancet Oncol. 2010;11(12):1160-1171.
11. Petignat P, Faltin DL, Bruchim I, Tramèr MR, Franco EL, Coutlee F. Are self-collected samples comparable to physician-collected cervical specimens for human papillomavirus DNA testing? A systematic review and meta-analysis. Gynecol Oncol. 2007;105(2):530-535. (Pubitemid 46590347)
12. Barbee L, Kobetz E, Menard J, et al. Assessing the acceptability of self-sampling for HPV among Haitian immigrant women: CBPR in action. Cancer Causes Control. 2010;21(3):421-431.
13. Gök M, Heideman DA, van Kemenade FJ, et al. HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study. BMJ. 2010;340:c1040.
14. Belinson JL, Qiao YL, Pretorius RG, et al. Shanxi Province cervical cancer screening study II: self-sampling for high-risk human papillomavirus compared to direct sampling for human papillomavirus and liquid based cervical cytology. Int J Gynecol Cancer. 2003;13(6):819-826. (Pubitemid 38235227)
15. Belinson JL, Hu S, Niyazi M, et al. Prevalence of type-specific human papillomavirus in endocervical, upper and lower vaginal, perineal and vaginal self-collected specimens: implications for vaginal self-collection. Int J Cancer. 2010;127(5):1151-1157.
16. Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA. 2002;287(16):2114-2119. (Pubitemid 34437346)
17. Zamora J, Abraira V, Muriel A, Khan K, Coomarasamy A. Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol. 2006;6:31.
18. Wright TC Jr, Denny L, Kuhn L, Pollack A, Lorincz A. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. JAMA. 2000;283(1):81-86. (Pubitemid 30038387)
19. Garcia F, Barker B, Santos C, et al. Cross-sectional study of patient-and physician-collected cervical cytology and human papillomavirus. Obstet Gynecol. 2003;102(2):266-272. (Pubitemid 36936997)
20. Szarewski A, Cadman L, Mallett S, et al. Human papillomavirus testing by self-sampling: assessment of accuracy in an unsupervised clinical setting. J Med Screen. 2007;14(1):34-42. (Pubitemid 46440364)
21. Bhatla N, Dar L, Patro AR, et al. Can human papillomavirus DNA testing of self-collected vaginal samples compare with physician-collected cervical samples and cytology for cervical cancer screening in developing countries? Cancer Epidemiol. 2009;33(6):446-450.
22. Balasubramanian A, Kulasingam SL, Baer A, et al. Accuracy and cost-effectiveness of cervical cancer screening by high-risk human papillomavirus DNA testing of self-collected vaginal samples. J Lower Genit Tract Dis. 2010;14(3):185-195.
23. Baldwin S, Santos C, Mendez Brown E, et al. Comparison of type-specific human papillomavirus data from self and clinician directed sampling. Gynecol Oncol. 2005;97(2):612-617. (Pubitemid 40614912)
24. Castle PE, Schiffman M, Bratti MC, et al. A population-based study of vaginal human papillomavirus infection of hysterectomized women. J Infect Dis. 2004;190(3):458-467. (Pubitemid 38982081)
25. Castle PE, Schiffman M, Glasss AG, et al. Human papillomavirus prevalence in women who have and have not undergone hysterectomies. J Infect Dis. 2006;194(12):1702-1705. (Pubitemid 44902001)
26. Winer RL, Lee SK, Hughes JP, Adam DE, Kiviat NB, Koutsky LA. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol. 2003;157(3):218-226. (Pubitemid 36152435)
27. Arbyn M, Sankaranarayanan R, Muwonge R, et al. Pooled analysis of the accuracy of five cervical cancer screening tests assessed in eleven studies in Africa and India. Int J Cancer. 2008;123(1):153-160. (Pubitemid 351705203)
28. Arbyn M, Bergeron C, Klinkhamer P, Martin-Hirsch P, Siebers AG, Bulten J. Liquid compared with conventional cervical cytology: a systematic review and meta-analysis. Obstet Gynecol. 2008;111(1):167-177.
29. Pretorius RG, Zhang WH, Belinson JL, et al. Colposcopically directed biopsy, random cervical biopsy, and endocervical curettage in the diagnosis of cervical intraepithelial neoplasia II or worse. Am J Obstet Gynecol. 2004;191(2):430-504.
30. Pretorius RG, Bao YP, Belinson JL, Burchette RJ, Smith JS, Qiao YL. Inappropriate gold standard bias in cervical cancer screening studies. Int J Cancer. 2007;121(10):2218-2224. (Pubitemid 47585601)
31. Tisci S, Shen YH, Fife D, et al. Patient acceptance of self-sampling for human papillomavirus in Rural China. J Low Genit Tract Dis. 2003;7(2):107-116. (Pubitemid 36469358)
32. Sowjanya AP, Paul P, Vedantham H, et al. Suitability of self-collected vaginal samples for cervical cancer screening in periurban villages in Andhra Pradesh, India. Cancer Epidemiol Biomarkers Prev. 2009;18(5):1373-1378.
33. Lenselink C, de Bie R, van Hamont D, et al. Detection and genotyping of human papillomavirus in self-obtained cervicovaginal samples by using the FTA Cartridge: new possibilities for cervical cancer screening. J Clin Microbiology. 2009;47(8):2564-2570.
34. Sankaranarayanan R, Esmy PO, Rajkumar R, et al. Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial. Lancet. 2007;370(9585):398-406. (Pubitemid 47176655)
35. Sankaranarayanan R, Gaffikin L, Jacob M, Sellors J, Robles S. A critical assessment of screening methods for cervical neoplasia. Int J Gynaecol Obstet. 2005;89(suppl 2):S4-S12. (Pubitemid 40488754)
36. Ngoma T, Muwonge R, Mwaiselage J, Kawegere J, Bukori P, Sankaranarayanan R. Evaluation of cervical visual inspection screening in Dar es Salaam, Tanzania. Int J Gynaecol Obstet. 2010;109(2):100-104.
37. Castle PE, Katki HA. Benefits and risks of HPV testing in cervical cancer screening. Lancet Oncol. 2010;11(13):214-215.
38. Goldie SJ, Gaffikin L, Goldhaber-Fiebert JD, et al. Cost-effectiveness of cervical-cancer screening in five developing countries. N Engl J Med. 2005;353(20):2158-2168. (Pubitemid 41653107)
39. Qiao YL, Sellors JW, Eder PS, et al. A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China. Lancet Oncol. 2008;9(10):929-936.
40. Arbyn M, Walker A, Meijer C. Comment: HPV-based cervical-cancer screening in China. Lancet Oncol. 2010;11(12):1112-1113.
41. Zhang D, Unschuld PU. Comment: China's barefoot doctor: past, present, and future. Lancet. 2008;372(9653):1865-1867.
42. Liu Q, Wang B, Kong Y, Cheng KK. China's primary health-care reform. Lancet. 2011;377(9783):2064-2066.